ERGIC3 Antikörper (AA 47-341) (FITC)
-
- Target Alle ERGIC3 Antikörper anzeigen
- ERGIC3 (ERGIC and Golgi 3 (ERGIC3))
-
Bindungsspezifität
- AA 47-341
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ERGIC3 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Endoplasmic reticulum-Golgi intermediate compartment protein 3 protein (47-341AA)
- Isotyp
- IgG
- Top Product
- Discover our top product ERGIC3 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- ERGIC3 (ERGIC and Golgi 3 (ERGIC3))
- Andere Bezeichnung
- ERGIC3 (ERGIC3 Produkte)
- Hintergrund
-
Background: Possible role in transport between endoplasmic reticulum and Golgi.
Aliases: 2310015B14Rik antibody, AV318804 antibody, C20orf47 antibody, CGI 54 antibody, D2Ucla1 antibody, dJ477O4.2 antibody, DKFZp547A2190 antibody, Endoplasmic reticulum Golgi intermediate compartment protein 3 antibody, endoplasmic reticulum localized protein ERp43 antibody, Endoplasmic reticulum-Golgi intermediate compartment protein 3 antibody, ERGI3_HUMAN antibody, ERGIC and golgi 3 antibody, ergic3 antibody, ERV46 antibody, NY BR 84 antibody, PRO0989 antibody, RP23-220D12.2 antibody, RP3-477O4.1 antibody, SDBCAG84 antibody, Serologically defined breast cancer antigen 84 antibody, Serologically defined breast cancer antigen NY BR 84 antibody, Serologically defined breast cancer antigen NY-BR-84 antibody
- UniProt
- Q9Y282
-